FPP-005

N/A

Report date: 2023/09/01 17:41:22
NME

Base Information

Drug NameFPP-005
Drug Alias NameFPP-005FPP005
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAnti-Interleukin-23
TargetsInterleukin-23
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFunPep Co LtdOsaka University
China Registration ClassN/A

Develop Information

Active CompaniesFunPep Co Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A